Overview

Safety and Tolerability of MK0773 in Healthy Older Men (0773-004)

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of MK0773 in healthy older men.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate